TITLE

Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience

AUTHOR(S)
Donghong Zhang; Zuoyi Jiao; Jixiang Han; Hongtai Cao
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4057
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436124

 

Related Articles

  • Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation. Chan, Kun-Ming; Wu, Tsung-Han; Cheng, Chih-Hsien; Lee, Chen-Fang; Wu, Ting-Jung; Chou, Hong-Shiue; Lee, Wei-Chen // Journal of Gastrointestinal Surgery;Feb2020, Vol. 24 Issue 2, p353 

    Background: Chronic viral hepatitis remains a major etiology of liver cirrhosis and hepatocellular carcinoma. Liver transplantation has been considered an effective treatment for this condition. This study aims to analyze living donor liver transplantation for patients with...

  • LIVER.  // American Journal of Gastroenterology;Sep2005 Supplement 2, Vol. 100, pS103 

    The article presents abstracts of research papers related to the liver. They include "Liver Transplantation in Severely Obese Patients: A Single Center Experience," "Recurrent Hepatitis C after Living Donor Liver Transplantation Detected by Tc-99m GSA Liver Scintigraphy," "Comparison of Limited...

  • A Review of Hepatitis B Management in Pre- and Post-Liver Transplant Recipients. Mukherjee, Sandeep // Open Immunology Journal;2010, Vol. 3, p27 

    Liver transplantation was approved for treatment of decompensated cirrhosis in the United States in 1983. Hepatitis B and hepatitis C viruses are the leading causes of liver transplantation for viral hepatitis and hepatitis B is also an important cause of liver transplantation for called acute...

  • Hepatitis B and Liver Transplantation. Mukherjee, Sandeep; Mukherjee, Urmila // Current Drug Therapy;Sep2009, Vol. 4 Issue 3, p194 

    Liver transplantation was approved for the treatment of decompensated cirrhosis in the United States in 1983. Hepatitis B and hepatitis C viruses are the leading causes of liver transplantation for viral hepatitis and hepatitis B is also an important cause of liver transplantation for fulminant...

  • Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Féray, Cyrille; Gigou, Michèle; Samuel, Didier; Ducot, Béatrice; Maisonneuve, Pascale; Reynès, Michel; Bismuth, Alain; Bismuth, Henri; Féray, C; Gigou, M; Samuel, D; Ducot, B; Maisonneuve, P; Reynès, M; Bismuth, A; Bismuth, H // Annals of Internal Medicine;05/15/98, Vol. 128 Issue 10, p810 

    Background: Recurrence of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection after liver transplantation is a clinical problem. Polyclonal immunoglobulins against hepatitis B surface antigen (HBIGs) prevent the recurrence of HBV infection, but no effective prophylaxis is...

  • A case report of de novo hepatocellular carcinoma after living donor liver transplantation. Songfeng Yu; Hua Guo; Li Zhuang; Jun Yu; Sheng Yan; Min Zhang; Weilin Wang; Shusen Zheng // World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1 

    Post-transplant malignancy is the major cause of later death of recipients after liver transplantation. Tumor recurrence after liver transplantation for patients with hepatocellular carcinoma in the end stage of cirrhosis has been frequently encountered. However, de novo hepatocellular carcinoma...

  • Prevention of Fungal and Hepatitis Virus Infections in Liver Transplantation. Paya, Carlos V. // Clinical Infectious Diseases;7/1/2001 Supplement 1, Vol. 33, pS47 

    Discusses invasive fungal infections and the recurrence of hepatitis B virus and hepatitis C virus infections in orthotopic liver transplant recipients. Risk factors for fungal infections; Background and epidemiology of Candida species infection; Preventive measures.

  • New indications.  // Formulary;May2007, Vol. 42 Issue 5, p282 

    The article focuses on the HepaGam B, a sterile solution of purified hepatitis B immune globulin (HBIG), a recommended treatment for the recurrence of Hepatitis B after a liver transplantation. It provides passive immunization for patients vulnerable to hepatitis B virus through combination with...

  • MANAGEMENT OF HEPATITIS B IN THE PERI-TRANSPLANT PERIOD. Saigal, Sanjiv; Basnotra, Amit; Soin, A. S. // Hepatitis B Annual;2009, Vol. 6, p29 

    Hepatitis B virus (HBV) infection is an important indication for liver transplantation worldwide. The most important concern is the prevention of viral recurrence in the post transplant period. With the introduction of Hepatitis B immunoglobulin, there has been a significance reduction in the...

  • Liver Transplantation for Alcoholic Liver Disease with or Without Hepatitis C. Goldar-Najafi, Atoussa; Gordon, Fredric D.; Lewis, W. David; Pomfret, Elizabeth; Pomposelli, James J.; Jenkins, Roger L.; Khettry, Urmila // International Journal of Surgical Pathology;Apr2002, Vol. 10 Issue 2, p115 

    Examines the impact of concomitant hepatitis C virus (HCV) on alcoholic liver disease patients undergoing liver transplantation (LT). Number of patients with cirrhosis at LT; List of native liver features; Recurrence of post-LT HCV.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics